The Precision Peptide Company Inc. (CSE:BPC)
Canada flag Canada · Delayed Price · Currency is CAD
0.3950
-0.0250 (-5.95%)
At close: Mar 20, 2026

CSE:BPC Income Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
0.050.010.290.580.12
Revenue Growth (YoY)
307.47%-95.73%-50.84%394.79%-
Cost of Revenue
0.030.070.320.540.13
Gross Profit
0.02-0.06-0.030.04-0.01
Selling, General & Admin
2.160.791.230.820.28
Research & Development
0.030.03---
Operating Expenses
2.270.961.610.940.28
Operating Income
-2.25-1.02-1.64-0.9-0.3
Interest & Investment Income
0.01----
Currency Exchange Gain (Loss)
-0.030-0.01-0.01-0
Other Non Operating Income (Expenses)
----0.19-
EBT Excluding Unusual Items
-2.28-1.02-1.65-1.09-0.3
Impairment of Goodwill
-0.88----
Asset Writedown
-1.37-0.01-0.01-0.04-
Pretax Income
-4.53-1.03-1.66-1.13-0.3
Net Income
-4.53-1.03-1.66-1.13-0.3
Net Income to Common
-4.53-1.03-1.66-1.13-0.3
Shares Outstanding (Basic)
227651
Shares Outstanding (Diluted)
227651
Shares Change (YoY)
224.08%17.56%24.54%589.41%-
EPS (Basic)
-0.21-0.15-0.29-0.25-0.45
EPS (Diluted)
-0.21-0.15-0.29-0.25-0.45
Free Cash Flow
-2.33-0.44-0.98-0.72-0.95
Free Cash Flow Per Share
-0.11-0.07-0.17-0.16-1.43
Gross Margin
44.15%--11.48%7.04%-10.69%
Operating Margin
-4529.94%-8354.01%-575.40%-154.78%-252.00%
Profit Margin
-9104.28%-8450.19%-581.35%-194.13%-252.86%
Free Cash Flow Margin
-4694.10%-3601.16%-343.39%-123.69%-808.45%
EBITDA
-2.16-1.02-1.64-0.9-0.29
EBITDA Margin
----154.64%-250.67%
D&A For EBITDA
0.090000
EBIT
-2.25-1.02-1.64-0.9-0.3
EBIT Margin
----154.78%-252.00%
Advertising Expenses
0.590.040.380.27-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.